MRI-guided Focused Ultrasound Therapy Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, End User, and Geography

Description

List of Tables

The MRI-guided focused ultrasound therapy market size is expected to grow from US$ 441.73 million in 2025 to US$ 1,027.63 million by 2034; it is projected to register a CAGR of 10.0% during 2026-2034. The rising prevalence of targeted diseases, technological advancements and regulatory approvals, and the shift towards noninvasive therapies and an aging population are noteworthy factors contributing to the expansion of the MRI-guided focused ultrasound therapy market size. Additionally, the development of portable and hybrid systems, and enhanced imaging and real-time thermometry are projected to bring new MRI-guided focused ultrasound therapy market trends in the near future.

The development of advanced imaging techniques together with instantaneous temperature measurement capabilities in MRgFUS treatment applications enables precise monitoring which guarantees safe and efficient tissue destruction through temperature mapping that requires no surgical intervention. The proton resonance frequency shift-based MR thermometry system accurately tracks HIFU temperature changes, which enables doctors to monitor their operations throughout the entire procedure. The PRF thermometry system in transcranial MRgFUS evaluates technical aspects of its clinical use to achieve precise monitoring of lesion development. The system relies on real-time ultrasound thermography (UST) which functions as an alternative to MR. The system uses graphics processing unit (GPU) technology to deliver economic monitoring solutions that operate at increased speeds while maintaining established monitoring methods which date back to the 1950s through its implementation after the medical field accepted MRgFUS technology. The system uses intelligence-based thermography (IT) technology to monitor FUS treatment while researchers assess new methods to oversee thermal management. MR thermometry in palliative MRgHIFU bone metastasis treatment provides better results in osteolytic bone-destroying lesions compared to upper body areas which show lower results according to evidence from multiple clinical treatments. The 7T MRI system enables real-time thermometry which monitors hyperthermia and drug delivery activities during treatment of patients, showing effective results in preclinical FUS systems. The techniques provide better protection as they enable exact procedures for both targeting and system supervision. The use of ultrasound-based solutions like UST provides a pathway to enhance the accessibility of image-guided FUS (IgFUS) technology which will promote its wider implementation. The advanced imaging method combines photoacoustic tomography with other techniques to achieve better tissue visualization results. Real-time thermometry helps predict and achieve controlled cell death patterns, in tumor treatments where excessive energy absorption must be avoided through careful and precise targeting, thereby emerging as a significant trend in the MRI-guided focused ultrasound therapy market.

End User-Based Insights

Based on end user, the MRI-guided focused ultrasound therapy market is segmented into healthcare facilities, diagnostic imaging centers, and research centers. The healthcare facilities segment held the largest MRI-guided focused ultrasound therapy market share in 2025. The healthcare facilities have adopted MR-guided focused ultrasound (MRgFUS) therapy as an essential treatment method because it enables hospitals and clinics to provide non-surgical solutions for patients who have essential tremor and Parkinson's disease and uterine fibroids and bone metastases. The Stanford Health Care facility has used MRgFUS since 2013 to treat essential tremor and Parkinson's disease and prostate cancer and bone metastases and uterine fibroids because it enables doctors to destroy specific body tissues while keeping adjacent areas intact according to their clinical program descriptions. The University of Maryland Medical Center (UMMC) developed MRgFUS as a treatment for essential tremor and Parkinson's-related tremors because its researchers conducted FDA clinical trials which led to system approval and now study its use for glioblastoma treatment in functional neurosurgery procedures. The UK-based Imperial College Healthcare NHS Trust applied MRgFUS through specialized equipment grants to treat essential tremor while using the technology to treat patients who have low-grade prostate cancer and uterine fibroids in outpatient settings.

Phased array technology enables skull penetration which allows brain procedures to occur without craniotomy, resulting in better patient outcomes and more efficient medical operations. The FDA approved uterine fibroid treatments in 2004 and bone metastasis treatments in 2012, which led to faster adoption of these procedures, while ongoing breast and liver and prostate cancer trials work toward achieving widespread clinical endorsement. This evolution supports multidisciplinary teams in delivering targeted therapy, minimizing hospital stays, and enhancing quality of life for patients with refractory conditions, thereby fueling the MRI-guided focused ultrasound therapy market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the MRI-guided focused ultrasound therapy market report.

Product Code: TIPRE00042234

1. Executive Summary

1.1 Analyst Market Outlook
1.2 Market Attractiveness

2. MRI-guided Focused Ultrasound Therapy Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 PEST Analysis
2.5 Impact of Artificial Intelligence (AI)
2.6 Product or Technology Roadmap
2.7 Sustainability and ESG Trends
2.8 Regulatory Framework

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. MRI-guided Focused Ultrasound Therapy Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Targeted Diseases
- 4.1.2 Technological Advancements and Regulatory Approvals
- 4.1.3 Shift Towards Noninvasive Therapies and Aging Population
4.2 Market Restraints
- 4.2.1 Regulatory and Approval Challenges
- 4.2.2 Technical Limitations and Safety Concerns
- 4.2.3 Lack of Skilled Professionals
4.3 Market Opportunities
- 4.3.1 Expansion into Oncology Applications
- 4.3.2 Growth in Emerging Economies
- 4.3.3 New Product Launches and Innovations
4.4 Future Trends
- 4.4.1 AI-Driven Treatment Planning and Automation
- 4.4.2 Development of Portable and Hybrid Systems
- 4.4.3 Enhanced Imaging and Real-Time Thermometry
4.5 Impact of Drivers and Restraints

5. MRI-guided Focused Ultrasound Therapy Market - Global Market Analysis

5.1 MRI-guided Focused Ultrasound Therapy Market Revenue (US$ Million), 2021-2034
5.2 MRI-guided Focused Ultrasound Therapy Market Forecast and Analysis

6. MRI-guided Focused Ultrasound Therapy Market Revenue Analysis -Application

6.1 MRI-guided Focused Ultrasound Therapy Market Forecasts and Analysis by Application
- 6.1.1 Breast Cancer
  - 6.1.1.1 Overview
  - 6.1.1.2 Breast Cancer: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
  - 6.1.1.3 Breast Cancer
    - 6.1.1.3.1 Benign
- 6.1.2 Prostate Cancer
  - 6.1.2.1 Overview
  - 6.1.2.2 Prostate Cancer: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
- 6.1.3 Liver Cancer
  - 6.1.3.1 Overview
  - 6.1.3.2 Liver Cancer: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
- 6.1.4 Pancreatic Cancer
  - 6.1.4.1 Overview
  - 6.1.4.2 Pancreatic Cancer: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
- 6.1.5 Breast Lifting and Aesthetic Application
  - 6.1.5.1 Overview
  - 6.1.5.2 Breast Lifting and Aesthetic Application: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
- 6.1.6 Nipple and Areola Preservation
  - 6.1.6.1 Overview
  - 6.1.6.2 Nipple and Areola Preservation: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
- 6.1.7 Post Surgical Applications
  - 6.1.7.1 Overview
  - 6.1.7.2 Post Surgical Applications: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
- 6.1.8 Other Applications
  - 6.1.8.1 Overview
  - 6.1.8.2 Other Applications: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)

7. MRI-guided Focused Ultrasound Therapy Market Revenue Analysis -End User

7.1 MRI-guided Focused Ultrasound Therapy Market Forecasts and Analysis by End User
- 7.1.1 Healthcare Facilities
  - 7.1.1.1 Overview
  - 7.1.1.2 Healthcare Facilities: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
- 7.1.2 Diagnostic Imaging Centers
  - 7.1.2.1 Overview
  - 7.1.2.2 Diagnostic Imaging Centers: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)
- 7.1.3 Research Centers
  - 7.1.3.1 Overview
  - 7.1.3.2 Research Centers: MRI-guided Focused Ultrasound Therapy Market -Revenue, 2021-2034 (US$ Million)

8. MRI-guided Focused Ultrasound Therapy Market - Geographical Analysis

8.1 North America
- 8.1.1 North America MRI-guided Focused Ultrasound Therapy Market Overview
- 8.1.2 North America: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.1.3 North America: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
  - 8.1.3.1 Application
    - 8.1.3.1.1 Breast Cancer
    - 8.1.3.1.2 Benign
  - 8.1.3.2 End User
- 8.1.4 North America: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
  - 8.1.4.1 United States Market
    - 8.1.4.1.1 United States: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.1.2 United States: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.1.4.1.2.1 Application
        
        8.1.4.1.2.1.1 Breast Cancer
        8.1.4.1.2.1.1.1 Benign
      - 8.1.4.1.2.2 End User
  - 8.1.4.2 Canada Market
    - 8.1.4.2.1 Canada: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.2.2 Canada: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.1.4.2.2.1 Application
        
        8.1.4.2.2.1.1 Breast Cancer
        8.1.4.2.2.1.1.1 Benign
      - 8.1.4.2.2.2 End User
  - 8.1.4.3 Mexico Market
    - 8.1.4.3.1 Mexico: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.1.4.3.2 Mexico: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.1.4.3.2.1 Application
        
        8.1.4.3.2.1.1 Breast Cancer
        8.1.4.3.2.1.1.1 Benign
      - 8.1.4.3.2.2 End User
8.2 Europe
- 8.2.1 Europe MRI-guided Focused Ultrasound Therapy Market Overview
- 8.2.2 Europe: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.2.3 Europe: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
  - 8.2.3.1 Application
    - 8.2.3.1.1 Breast Cancer
      - 8.2.3.1.1.1 Benign
  - 8.2.3.2 End User
- 8.2.4 Europe: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
  - 8.2.4.1 Germany Market
    - 8.2.4.1.1 Germany: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.1.2 Germany: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.2.4.1.2.1 Application
        
        8.2.4.1.2.1.1 Breast Cancer
        8.2.4.1.2.1.1.1 Benign
      - 8.2.4.1.2.2 End User
  - 8.2.4.2 United Kingdom Market
    - 8.2.4.2.1 United Kingdom: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.2.2 United Kingdom: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.2.4.2.2.1 Application
        
        8.2.4.2.2.1.1 Breast Cancer
        8.2.4.2.2.1.1.1 Benign
      - 8.2.4.2.2.2 End User
  - 8.2.4.3 France Market
    - 8.2.4.3.1 France: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.3.2 France: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.2.4.3.2.1 Application
        
        8.2.4.3.2.1.1 Breast Cancer
        8.2.4.3.2.1.1.1 Benign
      - 8.2.4.3.2.2 End User
  - 8.2.4.4 Italy Market
    - 8.2.4.4.1 Italy: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.4.2 Italy: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.2.4.4.2.1 Application
        
        8.2.4.4.2.1.1 Breast Cancer
        8.2.4.4.2.1.1.1 Benign
      - 8.2.4.4.2.2 End User
  - 8.2.4.5 Spain Market
    - 8.2.4.5.1 Spain: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.5.2 Spain: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.2.4.5.2.1 Application
        
        8.2.4.5.2.1.1 Breast Cancer
        8.2.4.5.2.1.1.1 Benign
      - 8.2.4.5.2.2 End User
  - 8.2.4.6 Rest of Europe Market
    - 8.2.4.6.1 Rest of Europe: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.2.4.6.2 Rest of Europe: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.2.4.6.2.1 Application
        
        8.2.4.6.2.1.1 Breast Cancer
        8.2.4.6.2.1.1.1 Benign
      - 8.2.4.6.2.2 End User
8.3 Asia Pacific
- 8.3.1 Asia Pacific MRI-guided Focused Ultrasound Therapy Market Overview
- 8.3.2 Asia Pacific: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.3.3 Asia Pacific: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
  - 8.3.3.1 Application
    - 8.3.3.1.1 Breast Cancer
      - 8.3.3.1.1.1 Benign
  - 8.3.3.2 End User
- 8.3.4 Asia Pacific: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
  - 8.3.4.1 China Market
    - 8.3.4.1.1 China: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.1.2 China: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.3.4.1.2.1 Application
        
        8.3.4.1.2.1.1 Breast Cancer
        8.3.4.1.2.1.1.1 Benign
      - 8.3.4.1.2.2 End User
  - 8.3.4.2 Japan Market
    - 8.3.4.2.1 Japan: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.2.2 Japan: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.3.4.2.2.1 Application
        
        8.3.4.2.2.1.1 Breast Cancer
        8.3.4.2.2.1.1.1 Benign
      - 8.3.4.2.2.2 End User
  - 8.3.4.3 India Market
    - 8.3.4.3.1 India: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.3.2 India: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.3.4.3.2.1 Application
        
        8.3.4.3.2.1.1 Breast Cancer
        8.3.4.3.2.1.1.1 Benign
      - 8.3.4.3.2.2 End User
  - 8.3.4.4 Australia Market
    - 8.3.4.4.1 Australia: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.4.2 Australia: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.3.4.4.2.1 Application
        
        8.3.4.4.2.1.1 Breast Cancer
        8.3.4.4.2.1.1.1 Benign
      - 8.3.4.4.2.2 End User
  - 8.3.4.5 South Korea Market
    - 8.3.4.5.1 South Korea: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.5.2 South Korea: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.3.4.5.2.1 Application
        
        8.3.4.5.2.1.1 Breast Cancer
        8.3.4.5.2.1.1.1 Benign
      - 8.3.4.5.2.2 End User
  - 8.3.4.6 Rest of APAC Market
    - 8.3.4.6.1 Rest of APAC: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.3.4.6.2 Rest of APAC: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.3.4.6.2.1 Application
        
        8.3.4.6.2.1.1 Breast Cancer
        8.3.4.6.2.1.1.1 Benign
      - 8.3.4.6.2.2 End User
8.4 Middle East and Africa
- 8.4.1 Middle East and Africa MRI-guided Focused Ultrasound Therapy Market Overview
- 8.4.2 Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.4.3 Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
  - 8.4.3.1 Application
    - 8.4.3.1.1 Breast Cancer
      - 8.4.3.1.1.1 Benign
  - 8.4.3.2 End User
- 8.4.4 Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
  - 8.4.4.1 Saudi Arabia Market
    - 8.4.4.1.1 Saudi Arabia: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.1.2 Saudi Arabia: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.4.4.1.2.1 Application
        
        8.4.4.1.2.1.1 Breast Cancer
        8.4.4.1.2.1.1.1 Benign
      - 8.4.4.1.2.2 End User
  - 8.4.4.2 South Africa Market
    - 8.4.4.2.1 South Africa: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.2.2 South Africa: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.4.4.2.2.1 Application
        
        8.4.4.2.2.1.1 Breast Cancer
        8.4.4.2.2.1.1.1 Benign
      - 8.4.4.2.2.2 End User
  - 8.4.4.3 United Arab Emirates Market
    - 8.4.4.3.1 United Arab Emirates: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.3.2 United Arab Emirates: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.4.4.3.2.1 Application
        
        8.4.4.3.2.1.1 Breast Cancer
        8.4.4.3.2.1.1.1 Benign
      - 8.4.4.3.2.2 End User
  - 8.4.4.4 Rest of Middle East and Africa Market
    - 8.4.4.4.1 Rest of Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.4.4.4.2 Rest of Middle East and Africa: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.4.4.4.2.1 Application
        
        8.4.4.4.2.1.1 Breast Cancer
        8.4.4.4.2.1.1.1 Benign
      - 8.4.4.4.2.2 End User
8.5 South and Central America
- 8.5.1 South and Central America MRI-guided Focused Ultrasound Therapy Market Overview
- 8.5.2 South and Central America: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 8.5.3 South and Central America: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
  - 8.5.3.1 Application
    - 8.5.3.1.1 Breast Cancer
      - 8.5.3.1.1.1 Benign
  - 8.5.3.2 End User
- 8.5.4 South and Central America: MRI-guided Focused Ultrasound Therapy Market Breakdown by Countries
  - 8.5.4.1 Brazil Market
    - 8.5.4.1.1 Brazil: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.1.2 Brazil: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.5.4.1.2.1 Application
        
        8.5.4.1.2.1.1 Breast Cancer
        8.5.4.1.2.1.1.1 Benign
      - 8.5.4.1.2.2 End User
  - 8.5.4.2 Argentina Market
    - 8.5.4.2.1 Argentina: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.2.2 Argentina: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.5.4.2.2.1 Application
        
        8.5.4.2.2.1.1 Breast Cancer
        8.5.4.2.2.1.1.1 Benign
      - 8.5.4.2.2.2 End User
  - 8.5.4.3 Rest of South and Central America Market
    - 8.5.4.3.1 Rest of South and Central America: MRI-guided Focused Ultrasound Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
    - 8.5.4.3.2 Rest of South and Central America: MRI-guided Focused Ultrasound Therapy Market- By Segmentation
      - 8.5.4.3.2.1 Application
        
        8.5.4.3.2.1.1 Breast Cancer
        8.5.4.3.2.1.1.1 Benign
      - 8.5.4.3.2.2 End User

9. MRI-guided Focused Ultrasound Therapy Market Industry Landscape

10. MRI-guided Focused Ultrasound Therapy Market - Key Company Profiles

10.1 Edap Tms SA
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Insightec Ltd.
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Koninklijke Philips NV
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 FUS Instruments Inc.
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Image Guided Therapy SA
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Profound Medical Corp.
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Arrayus Technologies Inc.
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 EpiSonica
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 NaviFUS Corp.
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Changjiangyuan Technology Development Co. Ltd.
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. List of Additional Companies Analyzed

11.1 List of Additional Companies Analyzed

12. Appendix

12.1 Glossary
12.2 Research Methodology and Approach
- 12.2.1 Secondary Research
- 12.2.2 Primary Research
- 12.2.3 Market Estimation Approach
  - 12.2.3.1 Supply Side Analysis
  - 12.2.3.2 Demand Side Analysis
- 12.2.4 Research Assumptions and Limitations
- 12.2.5 Currency Conversion
12.3 About The Insight Partners
12.4 Market Intelligence Cloud